Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrrolate versus penehyclidine for prevention of postoperative nausea and vomiting after painless gastrointestinal endoscopy
ChiCTR2500097073Phase 4Not yet recruiting
- Sponsor
- Henan Provincial Chest Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Glycopyrrolate group with Penehyclidine hydrochloride group (2 arms). Primary endpoint: Incidence of postoperative nausea and vomiting. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
glycopyrroniumpenehyclidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2500097073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097073.